•  
  •  
 

Abstract

Cadmium (Cd) is classified as a carcinogen in humans (IA). In addition to causing lung cancer, the incidence of prostate cancer due to Cd exposure based on epidemiological research has also increased. This study aims to identify the GSTP1 genotypic frequency distribution and its correlation with PSA and IGF-1 levels in Cd exposed and unexposed workers. The research design used was cross sectional in 23 exposed groups (weld workers) and 40 unexposed groups (office employees) with a total of 63 people. The measurement of PSA and IGF-1 levels was carried out using the ELISA method and identification of the GSTP1 gene polymorphism using the PCR-RFLP method. Data analysis using Mann-Whitney and Spearman correlation test. The results showed that there was a relationship between PSA levels and IGF1 (p0.05). There was a relationship between PSA and IGF1 (p0.05). There was a relationship between PSA and IGF1 (p0.05).

References

Julin B, Wolk A, Johansson JE, Andersson SO, Andren O, Akesson A. (2017). Dietary Cadmium Exposure and Prostate Cancer Incidence : a Population-based Prospective Cohort Study. Br J Cancer. 107(5):895-900.

Lin YS, Caffrey JL, Lin JW, Bayliss D, Faramawi MF, Bateson TF, et al. (2013). Increased Risk of Cancer Mortality Associated with Cadmium Exposures in Older Americans with Low Zinc Intake. J Toxicol Environ Health A.76(1):1-15.

Baade PD, Danny RY, Lauren JK. (2009). International Epidemiology of Prostate Cancer: Geographical Distribution and Secular Trends. Molecular Nutrition and Food Research.53: 171-172.

Aimola P, Carmignani M, Volpe AR, Di Benedetto A, Claudio L, Waalkes MP, et al. (2012). Cadmium Induces p-53Dependent Apoptosis in Human Prostate Epithelial Cells. Plos One.7(3):1-13.

Arriazu R, Duran E, Pozuelo JM, Santamaria L. (2013). Expression of Lysophosphatidi Acid Receptor 1 and Relation with Cell Proliferation, Apoptosis, and Angiogenesis on Preneoplastic Changes Induced by Cadmium Chloride in the Rat Ventral Prostate. Plos One.8(2) : 1-7.

Lacorte LM, Delella FK, Porto Amorim EM, Justulin LA Jr, Godinho AF, Almeida AA, et al. (2011). Early Changes Induced by Short-term Low-dose Cadmium Exposure in Rat Ventral and Dorsolateral Prostates. Microsc Res Tech. 75(11):988-97.

Chokkalingam AP, Pollack M, Fillmore CM, Gao YT, Stanckzyk FZ, Deng J, et al. (2001), Insulin-like Growth Factors and Prostate Cancer : A Population-based Case-Control Study in China. Cancer Epidemiol Biomarkers Prev,10(5):421-7.

Qadri Q, Sameer AS, Shah ZA, Hamid A, Alam S, Manzoor S, et al. (2011). Genetic Polymorphism of the GlutathioneS-Transferase P1 gene (GSTP1) and Susceptibility to Prostate Cancer in the Kashmiri Population. Gen Mol Res. 10(4):3038-45.

Rowlands MA, Gunnell D, Harris R, Vatten LJ, Holly JM, Martin RM. (2009). Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis. Int J Cancer. 124(10):2416– 2429.

Sharma A, Pandey A, Sharma S, Chatterjee I, Mehrotra R, Sehgal A, et al. (2014), Genetic polymorphism of glutathione S-transferase P1 (GSTP1) in Delhi population and comparison with other global populations. Meta Gene. 2:134–142.

Cao Y, Nimptsch K, Shui IM, Platz EA, Wu K, Pollak MN, et al. (2015) Prediagnostic plasma IGFBP-1, IGF-1 and risk of prostate cancer. Int J Cancer. May 15;136(10):2418-26.

Henningson MC1, Hietala M, Bågeman E, Olsson H, Jernström H. (2010). Interactions between oral contraceptive status and GSTM1 and GSTT1 deletions on insulin-like growth factor-1 (IGF-1) plasma levels in young healthy women. Growth Horm IGF Res. Dec;20(6):432-7.

Lima MM Jr, Oliveira MN, Granja F, Trindade AC, De Castro Santos LE, Ward LS. (2008). Lack of association of GSTT1, GSTM1, GSTO1, GSTP1 and CYP1A1 polymorphisms for susceptibility and outcome in Brazilian prostate cancer patients. Folia Biol (Praha). 54(3):102-8.

Wei B, Zhou Y, Xu Z, Ruan J, Cheng H, Zhu M, et al. (2013) GSTP1 Ile105Val Polymorphism and Prostate Cancer Risk: Evidence from a Meta-Analysis. PLoS ONE 8(8): e71640.

Roberts CT Jr. (2004). IGF-1 and prostate cancer. Novartis Found Symp. 262:193-9; discussion 199-204, 265-8

Download

Share

COinS